Keyphrases
Integrin
100%
Platelet Aggregation
100%
Thrombopoietin
100%
Costimulation
33%
Rap1b
33%
P2Y Receptors
33%
Phospholipase C
25%
Phosphoinositide 3-kinase (PI3K)
25%
P2Y12 Receptor
25%
Platelets
16%
Human Platelets
16%
Small GTPase
16%
Aggregation-induced
16%
Monoclonal Antibody
8%
Protein Kinase
8%
Signaling Pathway
8%
Ligation
8%
Induced Activation
8%
Mitogen-activated Protein Kinase
8%
LY294002
8%
U46619
8%
Fibrinogen
8%
Fast Activation
8%
Epinephrine
8%
Wortmannin
8%
Inside-out
8%
Cyclooxygenase Inhibitors
8%
ADP-induced Platelet Aggregation
8%
Thromboxane A2 (TXA2)
8%
Purinergic Receptors
8%
Thromboxane
8%
P2Y1
8%
PAC1
8%
Sustained Activation
8%
Biochemistry, Genetics and Molecular Biology
Thrombocyte Aggregation
100%
Thrombopoietin
100%
Integrin
100%
Adenosine Diphosphate
58%
Phosphoinositide 3-Kinase
25%
P2Y12
25%
Platelet
25%
Lecithinase
25%
Small GTPase
16%
Guanosine Triphosphate
8%
Mitogen-Activated Protein Kinase
8%
Protein Kinase C
8%
Agonist
8%
Monoclonal Antibody
8%
Kinase
8%
Phosphotransferase
8%
Thrombocyte Activation
8%
LY294002
8%
Cyclooxygenase
8%
Independent Pathway
8%
Epinephrine
8%
Purinergic Receptor
8%
U46619
8%
PAC-1
8%
Thromboxane A2
8%
Fibrinogen
8%
Thromboxane
8%
Pharmacology, Toxicology and Pharmaceutical Science
Integrin
100%
Thrombopoietin
100%
Adenosine Diphosphate
58%
Purinergic P2Y1 Receptor
41%
Purinergic P2Y12 Receptor
25%
Phosphatidylinositol 3 Kinase
25%
Lecithinase
25%
Receptor
16%
Guanosine Triphosphatase
16%
Guanosine Triphosphate
8%
Monoclonal Antibody
8%
Protein Kinase C
8%
Fibrinogen
8%
Thromboxane A2
8%
2 Morpholino 8 Phenylchromone
8%
Phosphotransferase
8%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
8%
Mitogen Activated Protein Kinase
8%
Epinephrine
8%
Wortmannin
8%
Prostaglandin Synthase Inhibitor
8%
Thromboxane
8%